	US 12,083,083 B2
	Antiviral compositions and methods for inactivating non-enveloped viruses using alkyl 2-hydroxycarboxylic acids
Daniel E. Pedersen, Saint Paul, MN (US); Hilina Emiru, Saint Paul, MN (US); and Carter M. Silvernail, Saint Paul, MN (US)
Assigned to ECOLAB USA INC., Saint Paul, MN (US)
Filed by ECOLAB USA INC., Saint Paul, MN (US)
Filed on Mar. 4, 2022, as Appl. No. 17/653,611.
Application 17/653,611 is a continuation of application No. 16/946,744, filed on Jul. 2, 2020, granted, now 11,298,329.
Application 16/946,744 is a continuation of application No. 15/720,636, filed on Sep. 29, 2017, granted, now 10,736,860, issued on Aug. 11, 2020.
Application 15/720,636 is a continuation of application No. 13/795,219, filed on Mar. 12, 2013, granted, now 9,808,435, issued on Nov. 7, 2017.
Prior Publication US 2022/0184010 A1, Jun. 16, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/19 (2006.01); A01N 25/30 (2006.01); A01N 31/02 (2006.01); A01N 37/36 (2006.01); A01N 41/02 (2006.01); A01N 41/04 (2006.01); A61K 31/045 (2006.01); A61K 31/20 (2006.01)

CPC A61K 31/19 (2013.01) [A01N 25/30 (2013.01); A01N 31/02 (2013.01); A01N 37/36 (2013.01); A01N 41/02 (2013.01); A01N 41/04 (2013.01); A61K 31/045 (2013.01); A61K 31/20 (2013.01)]

16 Claims

1. An antiviral concentrate having activity against non-enveloped viruses including norovirus comprising:

an alkyl 2-hydroxycarboxylic acid;

at least 0.5 wt. % of a sulfonated surfactant, wherein the sulfonated surfactant is one or more of hexyldiphenyl oxide disulfonate or a C₈-C₁₈alkyl diphenyl oxide disulfonate;

at least 30 wt. % of a C₁to C₆alcohol; and

water.